Zydus Lifesciences’ Diclofenac Sodium and Misoprostol Tablets gets FDA final approval
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to manufacture and market Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg. The approval marks a significant step in expanding the company’s portfolio in the United States pharmaceutical market. Diclofenac Sodium and Misoprostol tablets, generic for […]